Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
Saved in:
| Title: | Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma. |
|---|---|
| Authors: | Lozano-Calderón SA; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Albergo JI; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Italiano, Buenos Aires, Argentina., Groot OQ; Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Merchan NA; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Boston Children's Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., El Abiad JM; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, The Johns Hopkins Hospital, Johns Hopkins University, Baltimore, Maryland, USA., Salinas V; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Instituto Nacional de Cancerología, Bogotá, Colombia., Gomez Mier LC; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Instituto Nacional de Cancerología, Bogotá, Colombia., Montoya CS; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Instituto Nacional de Cancerología, Bogotá, Colombia., Ferrone ML; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Ready JE; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Linares FJ; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia., Levin AS; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, The Johns Hopkins Hospital, Johns Hopkins University, Baltimore, Maryland, USA., Peleteiro Pensado M; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Universitario La Paz, Madrid, Spain., Pozo Kreilinger JJ; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Universitario La Paz, Madrid, Spain., Ruiz IB; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Universitario La Paz, Madrid, Spain., Ortiz-Cruz EJ; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Universitario La Paz, Madrid, Spain., Gebhardt MC; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Boston Children's Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Cote GM; Division of Sarcoma and Connective Tissue Oncology, Department of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Choy E; Division of Sarcoma and Connective Tissue Oncology, Department of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Spentzos D; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Hung YP; Division of Bone and Soft Tissue Pathology, Department of Pathology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Deshpande V; Division of Bone and Soft Tissue Pathology, Department of Pathology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Chebib IA; Division of Bone and Soft Tissue Pathology, Department of Pathology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., McCulloch RA; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Royal Orthopedic Hospital National Health Service Trust, Aston University, Birmingham, UK., Farfalli G; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Italiano, Buenos Aires, Argentina., Aponte Tinao L; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Hospital Italiano, Buenos Aires, Argentina., Morris CD; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, The Johns Hopkins Hospital, Johns Hopkins University, Baltimore, Maryland, USA., Petur Nielsen G; Division of Bone and Soft Tissue Pathology, Department of Pathology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Anderson ME; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Boston Children's Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Jeys LM; Musculoskeletal Oncology Service, Department of Orthopedic Surgery, Royal Orthopedic Hospital National Health Service Trust, Aston University, Birmingham, UK. |
| Source: | Cancer [Cancer] 2023 Jan 01; Vol. 129 (1), pp. 60-70. Date of Electronic Publication: 2022 Oct 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.34506 |
